What
  • Brands
  • Deals
  • Dispensaries
  • Doctors
  • Strains
Where

Connecticut Medical Marijuana Card Online

How It Works

Medical Marijuana Card Doctors

Book Your Appointment

Skip unnecessary trips to the doctors office and do your appointment from the comfort of your home. Provide basic medical history and book your appointment.

Medical Marijuana Card Doctors

Match With a Doctor

Connect with the right marijuana doctor for you and easily talk to your provider on your phone or tablet. The provider will evaluate your condition and will address your questions.

Medical Marijuana Card Doctors

Get Your Medical Card

If approved for your CT medical marijuana card you will receive your approval email and depending on your location you can print your temporary card or will receive your card in the mail.


DESIGNED FOR
Anyone, Anywhere, at Anytime.

Medical Marijuana Card Doctors

Over 5,000+ Patients

Our Medical Cannabis community is made of over 5,000+ patients and is growing. Get your Connecticut Medical Marijuana Card and join the community.

Trusted Doctors

Our team vets board-certified marijuana doctors across the US for the best quality, well-matched resources for you. Always available.

Medical Marijuana Card Doctors

Don't Just Take Our Word For It.

FAQ: Connecticut Medical Marijuana Card

  • You must be able to provide proof of your Connecticut residency

    You are being treated for a debilitating medical condition by a Connecticut-licensed physician or advanced practice registered nurse.

  • Below are the medical conditions you must have by Illinois law. You must also have medical records from the last year that state you have this condition (doctor’s note is fine, but real medical records is the best). Again, we will help get this for you.
  •  
  • For Adults, Debilitating Medical Conditions Include:
  •  
  • • Cancer (Effective 2012)
  • • Glaucoma (Effective 2012)
  • • Positive Status for Human Immunodeficiency Virus or Acquired Immune Deficiency
  • • Syndrome (Effective 2012)
    • Parkinson’s Disease (Effective 2012)
    • Multiple Sclerosis (Effective 2012)
    • Damage to the Nervous Tissue of the Spinal Cord with Objective Neurological Indication of Intractable Spasticity (Effective 2012)
    • Epilepsy (Effective 2012)
    • Cachexia (Effective 2012)
    • Wasting Syndrome (Effective 2012)
    • Crohn’s Disease (Effective 2012)
    • Post-Traumatic Stress Disorder (Effective 2012)
    • Sickle Cell Disease (Effective 2016)*
    • Post Laminectomy Syndrome with Chronic Radiculopathy (Effective 2016)*
    • Severe Psoriasis and Psoriatic Arthritis (Effective 2016)*
    • Amyotrophic Lateral Sclerosis (Effective 2016)*
    • Ulcerative Colitis (Effective 2016)*
    • Complex Regional Pain Syndrome, Type 1 and Type II (Effective 2016)*
    • Cerebral Palsy (Effective 2016)
    • Cystic Fibrosis (Effective 2016)
    • Irreversible Spinal Cord Injury with Objective Neurological Indication of Intractable
  • • Spasticity (Effective 2016)
    • Terminal Illness Requiring End-Of-Life Care (Effective 2016)
    • Uncontrolled Intractable Seizure Disorder (Effective 2016)
    • Spasticity or Neuropathic Pain Associated with Fibromyalgia (Effective 2018)*
    • Severe Rheumatoid Arthritis (Effective 2018)*
    • Post Herpetic Neuralgia (Effective 2018)*
    • Hydrocephalus with Intractable Headache (Effective 2018)*
    • Intractable Headache Syndromes (Effective 2018)*
    • Neuropathic Facial Pain (Effective 2018)*
    • Muscular Dystrophy (Effective 2018)*
    • Osteogenesis Imperfecta (Effective 2018)*
  • • Chronic Neuropathic Pain Associated with Degenerative Spinal Disorders (Effective 2018)*
    • Interstitial Cystitis (Effective 2019)*
    • MALS Syndrome (Median Arcuate Ligament Syndrome) (Effective 2019)*
    • Vulvodynia and Vulvar Burning (Effective 2019)*
    • Intractable Neuropathic Pain that Is Unresponsive to Standard Medical Treatments (Effective 2019)*
    • Tourette Syndrome (Effective 2019)*
    • Chronic Pain of at least 6 months duration associated with a specified underlying chronic condition refractory to other treatment intervention (Effective 2020)*
    • Ehlers-Danlos Syndrome Associated with Chronic Pain (Effective 2020)*
  •  
  • For Patients Under 18, Debilitating Medical Conditions Include:

  • • Cerebral Palsy (Effective 2016)
    • Cystic Fibrosis (Effective 2016)
    • Irreversible Spinal Cord Injury with Objective Neurological Indication of Intractable
  • • Spasticity (Effective 2016)
    • Severe Epilepsy (Effective 2016)
    • Terminal Illness Requiring End-Of-Life Care (Effective 2016)
    • Uncontrolled Intractable Seizure Disorder (Effective 2016)
    • Muscular Dystrophy (Effective 2018)*
    • Osteogenesis Imperfecta (Effective 2018)*
    • Intractable Neuropathic Pain that Is Unresponsive to Standard Medical Treatments (Effective 2019)*
    • Tourette Syndrome for patients who have failed standard medical treatment (Effective 2019)*

  • * Conditions were approved by the Regulation Review Committee via the recommendation of the Board of Physicians and Commissioner of Consumer Protection.

Patients must register with the State of CT for a $100 fee.